282 related articles for article (PubMed ID: 16454837)
1. Contribution of IBD5 locus to clinical features of IBD patients.
Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V
Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837
[TBL] [Abstract][Full Text] [Related]
2. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
3. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
[TBL] [Abstract][Full Text] [Related]
4. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
[TBL] [Abstract][Full Text] [Related]
6. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
[TBL] [Abstract][Full Text] [Related]
7. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
8. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P
Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
[TBL] [Abstract][Full Text] [Related]
9. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
[TBL] [Abstract][Full Text] [Related]
11. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
[TBL] [Abstract][Full Text] [Related]
12. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
13. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
14. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
[TBL] [Abstract][Full Text] [Related]
15. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
[TBL] [Abstract][Full Text] [Related]
16. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
Russell RK; Drummond HE; Nimmo ER; Anderson NH; Noble CL; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
Gut; 2006 Aug; 55(8):1114-23. PubMed ID: 16469794
[TBL] [Abstract][Full Text] [Related]
18. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
19. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
[TBL] [Abstract][Full Text] [Related]
20. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
